Double-blind, randomized, placebo controlled study on the effects of the monophasic oral contraceptive containing 30 μg ethinyl estradiol and 2.00 mg dienogest on …
J Spona, W Feichtinger, C Kindermann, B Schneider… - Contraception, 1997 - Elsevier
Forty healthy female volunteers aged between 19 and 35 years (27.3±4.1 years) with normal
menstrual cycles were included in a double-blind, randomized, placebo-controlled study to
investigate the influence on the hemostatic system of an oral contraceptive containing 30 μg
ethinyl estradiol in combination with 2.00 mg dienogest, which is a 19-norprogestin without a
17α-ethinyl group. At baseline and during one treatment cycle, 12 hemostatic parameters
were measured on cycle days 7, 14, and 21. The hemostatic parameters were categorized …
menstrual cycles were included in a double-blind, randomized, placebo-controlled study to
investigate the influence on the hemostatic system of an oral contraceptive containing 30 μg
ethinyl estradiol in combination with 2.00 mg dienogest, which is a 19-norprogestin without a
17α-ethinyl group. At baseline and during one treatment cycle, 12 hemostatic parameters
were measured on cycle days 7, 14, and 21. The hemostatic parameters were categorized …
以上显示的是最相近的搜索结果。 查看全部搜索结果